Erlotinib Not Yet Recruiting Phase 2 Trials for Lung Cancers Treatment

IndicationsStatusPurposePhase
Not Yet RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02704767Tarceva With or Without Apatinib in the Advanced Lung Adenocarcinoma